Updated Jul 16, 2026
Bernstein Harold has filed 3 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $5.60M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-02 | MAZE | Maze Therapeutics, Inc. | S — Open-market sale | 1.2K | $30.34 | $36K |
| 2026-07-02 | MAZE | Maze Therapeutics, Inc. | S — Open-market sale | 13.4K | $29.86 | $400K |
| 2026-07-02 | MAZE | Maze Therapeutics, Inc. | M — Option exercise | 14.6K | $10.42 | $152K |
| 2026-06-03 | MAZE | Maze Therapeutics, Inc. | S — Open-market sale | 1.6K | $26.36 | $42K |
| 2026-06-03 | MAZE | Maze Therapeutics, Inc. | S — Open-market sale | 13.3K | $25.57 | $339K |
| 2026-06-03 | MAZE | Maze Therapeutics, Inc. | M — Option exercise | 14.9K | $10.42 | $155K |
| 2026-05-18 | MAZE | Maze Therapeutics, Inc. | S — Open-market sale | 15.0K | $26.22 | $393K |
| 2026-05-18 | MAZE | Maze Therapeutics, Inc. | M — Option exercise | 15.0K | $10.42 | $156K |
| 2026-04-02 | MAZE | Maze Therapeutics, Inc. | S — Open-market sale [10b5-1] | 300 | $31.07 | $9K |
| 2026-04-02 | MAZE | Maze Therapeutics, Inc. | S — Open-market sale [10b5-1] | 3.3K | $30.06 | $101K |
| 2026-04-02 | MAZE | Maze Therapeutics, Inc. | S — Open-market sale [10b5-1] | 11.4K | $29.24 | $332K |
| 2026-04-02 | MAZE | Maze Therapeutics, Inc. | M — Option exercise [10b5-1] | 15.0K | $10.42 | $156K |
| 2026-03-20 | MAZE | Maze Therapeutics, Inc. | S — Open-market sale [10b5-1] | 5.0K | $50.02 | $252K |
| 2026-03-20 | MAZE | Maze Therapeutics, Inc. | S — Open-market sale [10b5-1] | 3.8K | $49.32 | $187K |
| 2026-03-20 | MAZE | Maze Therapeutics, Inc. | S — Open-market sale [10b5-1] | 6.2K | $48.20 | $297K |
| 2026-03-20 | MAZE | Maze Therapeutics, Inc. | M — Option exercise [10b5-1] | 15.0K | $10.42 | $156K |
| 2026-03-12 | MAZE | Maze Therapeutics, Inc. | S — Open-market sale [10b5-1] | 348 | $51.02 | $18K |
| 2026-03-12 | MAZE | Maze Therapeutics, Inc. | S — Open-market sale [10b5-1] | 29.7K | $50.45 | $1.50M |
| 2026-03-12 | MAZE | Maze Therapeutics, Inc. | M — Option exercise [10b5-1] | 30.0K | $10.42 | $313K |
| 2026-02-04 | MAZE | Maze Therapeutics, Inc. | S — Open-market sale [10b5-1] | 100 | $47.23 | $5K |
Bernstein Harold is a corporate insider — currently tracked as Insider of Maze Therapeutics, Inc. (MAZE). InsiderAlpha tracks every SEC Form 4 filing in real time.
3 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 18 open-market sales ($5.60M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Bernstein Harold profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.